Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568827 · ClinicalTrials.gov registry record · Phase 1
Inflammation, Polyphenols, and Genetics
A Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01568827 is a Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 10 participants.
The verdict
NCT01568827, a Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Pilot study to determine whether daily consumption of blackraspberry powder (high in polyphenols) can reduce markers of inflammation and to determine whether genetics influence baseline levels of inflammatory markers as well as individual's response to polyphenols. A total of 10 males participated in this cross-over study.
Interventions
- DIETARY_SUPPLEMENT Blackraspberry Slurry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568827
The ClinicalTrials.gov registry entry for NCT01568827 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blackraspberry Slurry is the first listed.
NCT01568827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568827 about?
NCT01568827 is a clinical study titled "Inflammation, Polyphenols, and Genetics". Pilot study to determine whether daily consumption of blackraspberry powder (high in polyphenols) can reduce markers of inflammation and to determine whether genetics influence baseline levels of inflammatory markers as well as individual's response to polyphenols. A total of 10 males participated i...
What is the current status of trial NCT01568827?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2012-03. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01568827?
The interventions under investigation include: Blackraspberry Slurry (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01568827?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.